Effect of COX-2 Inhibitors Selectivity on Lipid Profile in Hyperlipidemic and Normolipidemic Type 2 Diabetics
Development of NSAIDS based on inhibiting cyclooxygenase activity. However, the different physiological consequences arrised by appearance of new drugs with different selectivity to COX-2 enzyme upon their administration with their relevant affects on some cardiovascular risk factors. To study the p...
Saved in:
Main Authors: | Najwan K. Fakree (Author), Shatha H. Ali (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy University of Baghdad,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of COX-2 Inhibitors Selectivity on Lipid Profile in Hyperlipidemic and Normolipidemic Type 2 Diabetics
by: Najwan K. Fakree, et al.
Published: (2017) -
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
by: Harris RE, et al.
Published: (2012) -
Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
by: Afaf A. El-Malah, et al.
Published: (2022) -
Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
by: Nathalie Moussa, et al.
Published: (2023) -
A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis
by: Ali Mohammed Hadi, et al.
Published: (2010)